Affymetrix Shares Primed For A Rebound
MarketScanners
•
Tue, Dec 13, 2011
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
495 people get AFFX articles and Market Currents by email alert.
Get email alerts on AFFX »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
Affymetrix Will Pay $330 Million To Acquire eBioscienceThe Burrill Report • Sun, Dec 4, 2011 -
-
-
Affymetrix Shorts Stand to GainData Explorers • Thu, Oct 22, 2009 -
Five Reasons to Invest in AffymetrixJames Levy • Mon, Jul 20, 2009 -
Affymetrix Lowers Outlook for Fourth Quarter and 2006 (AFFX)• Thu, Jan 5, 2006
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
Notable Insider Buys Filed On August 6StockPandit • Tue, Aug 7, 2012 -
10 High-Growth Stocks Under $5 Undervalued By Levered Free Cash FlowsKapitall • Thu, Jul 26, 2012
-
7 Highly Liquid Tech Stocks Positively Correlated With VolatilityKapitall • Thu, Jun 21, 2012
-
3 Outperforming Stocks Under $5 With Bearish Short TrendsKapitall • Fri, Jun 1, 2012
-
-
6 Small Cap Stocks With Plenty Of Cash On Hand And Strong Expected GrowthZetaKap • Thu, May 24, 2012
-
-
3 Highly Liquid Tech Stocks On Winning StreaksKapitall • Fri, May 18, 2012
-
-
-
-
-
-
Behind Roche's Pharmaceutical Shake UpJessica King Holden • Tue, Jan 31, 2012 -
-
Life Science Research Services Industry Needs Better TechnologiesGrant Zeng • Mon, Jan 23, 2012 -
20 Stocks Under $5 Being Snapped Up By InsidersKapitall • Thu, Jan 19, 2012
-
Affymetrix's CEO Discusses Q2 2011 Results - Earnings Call TranscriptWed, Jul 27, 2011
-
Affymetrix's CEO Discusses Q1 2011 Results - Earnings Call TranscriptThu, Apr 28, 2011
-
Affymetrix CEO Discusses Q4 2010 Results - Earnings Call TranscriptWed, Feb 2, 2011
-
Affymetrix CEO Discusses Q3 2010 Results - Earnings Call TranscriptWed, Oct 27, 2010
-
Affymetrix, Inc. Q2 2010 Earnings Call TranscriptWed, Jul 21, 2010
-
Affymetrix Inc. Q1 2010 Earnings Call TranscriptWed, Apr 21, 2010
-
Affymetrix Inc. F4Q09 Earnings Conference CallWed, Feb 3, 2010
-
Affymetrix, Inc. Q3 Earnings Call TranscriptWed, Oct 21, 2009
-
Affymetrix Q2 2009 Earnings TranscriptWed, Jul 22, 2009
-
Affymetrix, Inc., F1Q09 Earnings Call TranscriptWed, Apr 22, 2009
-
Affymetrix, Inc., Q4 2008 Earnings Call TranscriptWed, Jan 28, 2009
-
Affymetrix, Inc. Q3 2008 Earnings Call TranscriptSat, Oct 25, 2008
-
Business Wire (May 20, 2013)
-
Business Wire (Apr 30, 2013)
-
Business Wire (Apr 9, 2013)
-
Business Wire (Feb 7, 2013)
-
Business Wire (Feb 5, 2013)
-
Business Wire (Jan 31, 2013)
-
Business Wire (Jan 3, 2013)
-
Business Wire (Dec 3, 2012)
-
Business Wire (Nov 20, 2012)
-
Business Wire (Nov 6, 2012)
-
Business Wire (Nov 5, 2012)
-
Business Wire (Nov 1, 2012)
-
at MarketWatch.com (Oct 8, 2012)
-
at MarketWatch.com (Oct 8, 2012)
AFFX vs. ETF Alternatives
Company Description
We develop, manufacture and sell products and services for genetic analysis to the life science research and clinical healthcare markets. Researchers around the world use our technology to better understand the role that genes play in disease, the effectiveness and safety of therapies and many... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Monday, May 20, 4:09 PM Affymetrix (AFFX +1.4%) finishes higher after earlier appointing Gavin Wood to the position of Chief Financial Officer. Mr. Wood joined AFFX in 2006, having served most recently as VP Finance, International Controller based in the United Kingdom. Tim Barabe, the current CFO, is expected to retire effective June 28, 2013. Comment! [Healthcare, On the Move]
- Tuesday, April 30, 4:47 PM Affymetrix (AFFX): Q1 EPS of $0.01 beats by $0.01. Revenue of $77.9M misses by $2.06M. (PR) Comment! [Earnings, Breaking News, Tech]
- Tuesday, April 30, 12:10 AM Notable earnings after Tuesday’s close: ACAS, AFFX, AJG, AMRS, APU, ATLS, AUY, AVB, BCOV, BGC, BLMN, BXP, CAVM, CLD, CRAY, DDR, DENN, DGI, DWA, EEP, EIX, ELGX, ELLI, ENTR, EQR, EZPW, FEIC, FIRE, FISV, FLEX, FMC, FTNT, GDOT, GEVO, GNW, HCBK, HT, HTCH, IACI, INT, JIVE, JLL, JMBA, LEAP, MDU, MERU, MRGE, MSPD, MTW, MWA, MX, NANO, NCR, NUVA, OKE, OKS, PRAA, PRXL, QCOR, QEP, REXX, RGC, RPXC, SGI, SHOR, SIMG, SKT, SM, SONS, STR, SWI, TE, TRMB, TRN, UGI, ULTI, UNTD, UNXL, VNR, VRSK, VRTX, WNC, WRI, WU, XCO Comment! [Earnings]
- Monday, April 29, 5:35 PM Notable earnings after Tuesday’s close: ACAS, AFFX, AJG, AMRS, APU, ATLS, AUY, AVB, BCOV, BGC, BLMN, BXP, CAVM, CLD, CRAY, DDR, DENN, DGI, DWA, EEP, EIX, ELGX, ELLI, ENTR, EQR, EZPW, FEIC, FIRE, FISV, FLEX, FMC, FTNT, GDOT, GEVO, GNW, HCBK, HT, HTCH, IACI, INT, JIVE, JLL, JMBA, LEAP, MDU, MERU, MRGE, MSPD, MTW, MWA, MX, NANO, NCR, NUVA, OKE, OKS, PRAA, PRXL, QCOR, QEP, REXX, RGC, RPXC, SGI, SHOR, SIMG, SKT, SM, SONS, STR, SWI, TE, TRMB, TRN, UGI, ULTI, UNTD, UNXL, VNR, VRSK, VRTX, WNC, WRI, WU, XCO 2 Comments [Earnings]
- Tuesday, April 9, 10:00 AM Affymetrix (AFFX -12%) plummets after announcing preliminary Q1 revenue of $78M, missing analyst estimates of ~$83M. The company blamed "continued headwinds" in the gene expression business. Citing the pre-earnings quiet period, AFFX says it will make no further statements until its call on April 30. Comment! [Healthcare, On the Move]
- Thursday, January 31, 4:08 PM Affymetrix (AFFX): Q4 EPS of -$0.02 beats by $0.01. Revenue of $84.4M (+2% Y/Y) beats by $0.34M. Shares -0.8% AH. (PR) Comment! [Earnings, Breaking News, Tech]
- Thursday, January 31, 12:10 AM Notable earnings after Thursday’s close: AFFX, BCR, BKH, CAVM, CB, CTCT, CTRP, ED, EMN, FBHS, GDOT, MCK, MIPS, MITK, MTW, N, NGVC, PFG, PMCS, PWER, SPF, TLAB, TSYS, WYNN, ZOLT Comment! [Earnings]
- Wednesday, January 30, 5:35 PM Notable earnings after Thursday’s close: AFFX, BCR, BKH, CAVM, CB, CTCT, CTRP, ED, EMN, FBHS, GDOT, MCK, MIPS, MITK, MTW, N, NGVC, PFG, PMCS, PWER, SPF, TLAB, TSYS, WYNN, ZOLT Comment! [Earnings]
- Thursday, December 13, 2012, 11:21 AM Affymetrix (AFFX -0.8%) says it's subsidiary, eBioscience, has sold its TrueBlot IP/Western blot product line to Rockland Immunochemicals, a biotechnology company focusing on antibodies and antibody based tools for R&D and preclinical studies. TrueBlot reagents are used in Western blotting, a technique used in both scientific research and medical diagnosis to determine expression and quantitate target proteins in biological samples. Comment! [Healthcare, M&A]
- Monday, November 5, 2012, 4:18 PM Affymetrix (AFFX): Q3 EPS of -$0.03 beats by $0.02. Revenue of $38.1M (+24.4% Y/Y) in-line. (PR) Comment! [Earnings, Tech]
-
Monday, October 8, 2012, 12:45 PM
Midday top 10 gainers: OTT +18%. VRNG +17%. ALNC +17%. NBG +12%. TPCG +12%. BIOF +12%. FONR +11%. CECO +11%. NFLX +10%. DCTH +10%.
Top 10 Losers: GDOT -20%. REGI -20%. AFFX -15%. PRGS -13%. BTUI -11%. OCLR -9%. GSI -8%. XNPT -8%. EZPW -7%. UPIP -7%. Comment! - Monday, October 8, 2012, 12:27 PM Affymetrix's (AFFX -15%) warning that it’s seeing academic institutions pull back on spending could ripple through other science equipment makers, Mizuho analyst Peter Lawson says. While Mizuho continues to recommend AFFX as a Buy on valuation, it's trimming estimates and turns negative on academically-exposed names: ILMN +1%, LIFE -0.7%, FLDM -1.3%, TMO -0.6%. Comment! [Healthcare, Quick Ideas, On the Move]
-
Monday, October 8, 2012, 9:10 AM
Premarket gainers: TPCG +11%. VRNG +9%. NFLX +7%. MDRX +7%.
Losers: REGI -20%. GDOT -19%. NTSP -13%. AFFX -13%. Comment! [On the Move] - Monday, October 8, 2012, 7:19 AM Affymetrix (AFFX) says Q3 revenue will be about $80M, short of consensus $85M, due to concerns about tighter academic funding globally and euro weakness. Some $18M will come from its eBioscience business, without which revenues will be "flat to slightly down" for the year. Results are due after the close Oct. 31. Comment! [Tech, Healthcare]
- Tuesday, July 31, 2012, 4:08 PM Affymetrix (AFFX): Q2 EPS of -$0.02 beats by $0.06. Revenue of $66.4M (+2.6% Y/Y) beats by $0.8M. Shares -0.5% AH. (PR) Comment! [Earnings, Tech]
- Monday, July 2, 2012, 1:53 PM Affymetrix (AFFX -3%) slips after Goldman cut the shares to Sell on valuation, citing concerns that eBio won't be sufficient to stave off end market headwinds. Comment! [Healthcare, On the Move]
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Adjusted Return
I got back into Affymetrix (AFFX) @ $4.56 finally, also preparing for a buy at lower prices. Background here: http://seekingalpha.com/a/62ik - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Stock"Pops"
Stradles on LVS>CatAnge, SWKS>CatAnge, UNG>CatAnge, and, AFFX>CatAnge. Market needs to move! Exactly why I'm confident we'll move sideways...until my options expire! - View all 0 replies
-
- View all 0 replies
LATEST REPLIES